MX349493B - Composicion que sera aplicada a la piel, y usos de la misma. - Google Patents

Composicion que sera aplicada a la piel, y usos de la misma.

Info

Publication number
MX349493B
MX349493B MX2014003846A MX2014003846A MX349493B MX 349493 B MX349493 B MX 349493B MX 2014003846 A MX2014003846 A MX 2014003846A MX 2014003846 A MX2014003846 A MX 2014003846A MX 349493 B MX349493 B MX 349493B
Authority
MX
Mexico
Prior art keywords
skin
oil
composition
treatment
well
Prior art date
Application number
MX2014003846A
Other languages
English (en)
Other versions
MX2014003846A (es
Inventor
Nahavandi Ali
Original Assignee
Alnapharm Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnapharm Gmbh & Co Kg filed Critical Alnapharm Gmbh & Co Kg
Publication of MX2014003846A publication Critical patent/MX2014003846A/es
Publication of MX349493B publication Critical patent/MX349493B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Abstract

La presente invención se refiere a una composición para ser aplicada a la piel, caracterizada porque comprende: (1) un vehículo dermatológicamente compatible, (2) aceite de coco, (3) aceite de avellana y/o aceite de avellana napolitana, y (4) aceite de ortiga.
MX2014003846A 2011-09-30 2012-09-10 Composicion que sera aplicada a la piel, y usos de la misma. MX349493B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11007992.8A EP2574343B1 (de) 2011-09-30 2011-09-30 Zusammensetzung zum Auftragen auf die Haut und Verwendung derselben
PCT/EP2012/003802 WO2013045031A1 (en) 2011-09-30 2012-09-10 Composition to be applied to the skin, and use thereof

Publications (2)

Publication Number Publication Date
MX2014003846A MX2014003846A (es) 2015-01-16
MX349493B true MX349493B (es) 2017-08-01

Family

ID=46851932

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003846A MX349493B (es) 2011-09-30 2012-09-10 Composicion que sera aplicada a la piel, y usos de la misma.

Country Status (33)

Country Link
US (1) US20140234447A1 (es)
EP (1) EP2574343B1 (es)
JP (1) JP6034386B2 (es)
KR (1) KR101954057B1 (es)
CN (1) CN103841986B (es)
AP (1) AP2014007596A0 (es)
AU (1) AU2012314946B2 (es)
BR (1) BR112014007218B1 (es)
CA (1) CA2848922C (es)
CL (1) CL2014000756A1 (es)
CO (1) CO6930361A2 (es)
CY (1) CY1115039T1 (es)
DK (1) DK2574343T3 (es)
EA (1) EA023746B1 (es)
ES (1) ES2458124T3 (es)
GE (1) GEP20166495B (es)
GT (1) GT201400058A (es)
HK (1) HK1197037A1 (es)
HR (1) HRP20140386T1 (es)
IL (1) IL231589B (es)
MX (1) MX349493B (es)
MY (1) MY184014A (es)
PE (1) PE20141538A1 (es)
PL (1) PL2574343T3 (es)
PT (1) PT2574343E (es)
RS (1) RS53289B (es)
SG (1) SG11201400742PA (es)
SI (1) SI2574343T1 (es)
SM (1) SMT201400051B (es)
TN (1) TN2014000102A1 (es)
UA (1) UA113065C2 (es)
WO (1) WO2013045031A1 (es)
ZA (1) ZA201401941B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131053A1 (it) * 2013-06-25 2014-12-26 Maria Oliva Salviati Composizione che comprende ortica

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5381612A (en) * 1976-12-24 1978-07-19 Fuarumatsuoiteitsushiyu Fuabur Ointment for treating psoriasis vulgaris * lichen and eczema
DE3232136A1 (de) * 1982-08-28 1984-03-01 Ruth Cegla GmbH, 7542 Schömberg Gemisch enthaltend meersalz und/oder salinensalz
AU610551B2 (en) * 1987-12-23 1991-05-23 Psoricur Ltd. Therapeutical compositions against psoriasis
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
DE19504914C1 (de) * 1995-02-15 1995-11-16 Goldwell Gmbh Haarwaschmittel
US6752999B2 (en) * 1995-09-20 2004-06-22 Nicholas V. Perricone Method of skin care and/or treatment using lipoic acid
RU2127584C1 (ru) * 1996-02-29 1999-03-20 Коновалов Валерий Николаевич Мазь противовоспалительного, обезболивающего и ранозаживляющего действия (варианты)
RO113110B1 (ro) * 1997-02-13 1998-04-30 Sc Apollo Sa Săpun extrafin
US5997889A (en) * 1998-02-20 1999-12-07 Omnipotent Skin Products, L.L.C. Hand and body creme for the treatment of skin ailments
US7250174B2 (en) * 1999-12-07 2007-07-31 Schott Ag Cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same
US6673756B2 (en) * 2000-09-20 2004-01-06 Symrise Gmbh & Co. Kg Multiphase soaps
ITRM20030204A1 (it) * 2003-04-29 2004-10-30 Provincia Italiana Della Congregazi One Dei Figli Formulazione dermatologica.
US7060306B2 (en) * 2003-11-10 2006-06-13 Springstead Patricia R Skin formulation
US7390507B2 (en) * 2004-04-13 2008-06-24 Ruwart Mary J Compositions and methods for the treatment of radiation burns and other traumatic skin conditions
FR2888497B1 (fr) * 2005-07-13 2010-12-24 Oreal Procede de maquillage et/ou de soin cosmetique
US20080113033A1 (en) * 2006-11-13 2008-05-15 Hrk, Inc. Topical treatment and manufacturing method
DE102007036499A1 (de) * 2007-08-01 2009-02-05 Henkel Ag & Co. Kgaa Naturkosmetisches Haarbehandlungsmittel
FR2956813B1 (fr) * 2010-02-26 2012-07-27 Lea Lab Shampooing et son utilisation

Also Published As

Publication number Publication date
CL2014000756A1 (es) 2014-10-03
SMT201400051B (it) 2014-07-07
CN103841986A (zh) 2014-06-04
DK2574343T3 (da) 2014-04-28
CA2848922C (en) 2020-04-07
IL231589A0 (en) 2014-05-28
AU2012314946B2 (en) 2017-06-15
UA113065C2 (xx) 2016-12-12
JP2014527990A (ja) 2014-10-23
HRP20140386T1 (hr) 2014-08-01
CY1115039T1 (el) 2016-12-14
GEP20166495B (en) 2016-06-27
BR112014007218A2 (pt) 2017-04-04
ZA201401941B (en) 2015-09-30
SI2574343T1 (sl) 2014-06-30
AU2012314946A1 (en) 2014-05-15
SG11201400742PA (en) 2014-04-28
CN103841986B (zh) 2019-09-03
PL2574343T3 (pl) 2014-07-31
PE20141538A1 (es) 2014-11-18
MX2014003846A (es) 2015-01-16
HK1197037A1 (en) 2015-01-02
NZ623817A (en) 2015-07-31
EP2574343A1 (de) 2013-04-03
BR112014007218B1 (pt) 2020-12-15
US20140234447A1 (en) 2014-08-21
ES2458124T3 (es) 2014-04-30
CO6930361A2 (es) 2014-04-28
PT2574343E (pt) 2014-05-02
JP6034386B2 (ja) 2016-11-30
GT201400058A (es) 2015-10-15
EA201400399A1 (ru) 2014-07-30
IL231589B (en) 2019-07-31
RS53289B (en) 2014-08-29
WO2013045031A1 (en) 2013-04-04
EA023746B1 (ru) 2016-07-29
MY184014A (en) 2021-03-17
KR20140090985A (ko) 2014-07-18
KR101954057B1 (ko) 2019-05-22
EP2574343B1 (de) 2014-01-29
TN2014000102A1 (en) 2015-07-01
CA2848922A1 (en) 2013-04-04
AP2014007596A0 (en) 2014-04-30

Similar Documents

Publication Publication Date Title
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MX346602B (es) Compuestos beta-lactamicos sustituidos con amidina, su preparacion y uso como agentes antibacterianos.
MX2015001719A (es) Composiciones cosmeticas.
MX368959B (es) Inhibidores heteroarilo de pde4.
WO2014031928A3 (en) Heterocyclic modulators of hif activity for treatment of disease
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
WO2013163190A8 (en) Dna-pk inhibitors
WO2012045089A3 (en) Methods for the treatment of allergic diseases
WO2013013815A8 (en) Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands
MY180751A (en) 3,4-dihydroisoquinolin-2(1h)-yl compounds
GEP20166554B (en) Nitrogenated heterocyclic compound
WO2013165921A3 (en) Therapeutic use of chardonnay seed products
WO2014031933A3 (en) Heterocyclic modulators of hif activity for treatment of disease
MX2016003823A (es) Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma.
WO2014031936A3 (en) Heterocyclic modulators of hif activity for treatment of disease
WO2013098416A3 (fr) Composes anti-douleur
CL2014003123A1 (es) 5-amino [1,4], tiazinas como inhibidores de bace1; uso del compuesto contra la enfermedad de alzheimer.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
WO2012104823A3 (en) Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
NZ704178A (en) Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
TN2014000102A1 (en) Composition to be applied to the skin, and use thereof
EA201400606A1 (ru) Полиолефиновое волокно
MX2013006670A (es) Derivado de 2-carboxamida-4-piperazinil-benzofurano.
IN2015MN00091A (es)
WO2013064326A3 (de) Arjunolsäure zur erhöhung der sebumproduktion

Legal Events

Date Code Title Description
FG Grant or registration